MedTrace Logo

Optical Imaging of Head and Neck Cancer

NCT01456143 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2018-02-01

Study results available
· View outcomes & findings →

Summary

This study examines if certain imaging techniques and devices can aid the surgeon in detecting cancer during the surgical procedure.

Conditions

Interventions

DEVICE

High Resolution Microendoscopy (HRME)

High Resolution Microendoscopy imaging device that operates as a fluorescence microscope with a fiber optic imaging probe. The probe is placed against the mucosa to obtain images relayed to a tablet computer.

OTHER

Proflavine hemisulfate

0.01% Proflavine hemisulfate used as a fluorescent contrast agent applied topically to mucosa

Sponsors & Collaborators

  • William Marsh Rice University

    collaborator OTHER

  • Sharmila Anandasabapathy, MD

    lead INDIV

Principal Investigators

  • Andrew Sikora, MD, PhD · Icahn School of Medicine at Mount Sinai

  • Sharmila Anandasabapathy, MD · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01456143 on ClinicalTrials.gov